Cargando…

Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb

BACKGROUND: It has been proposed, and preclinically demonstrated, that (161)Tb is a better alternative to (177)Lu for the treatment of small prostate cancer lesions due to its high emission of low-energy electrons. (161)Tb also emits photons suitable for single-photon emission computed tomography (S...

Descripción completa

Detalles Bibliográficos
Autores principales: Marin, I., Rydèn, T., Van Essen, M., Svensson, J., Gracheva, N., Köster, U., Zeevaart, J. R., van der Meulen, N. P., Müller, C., Bernhardt, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329978/
https://www.ncbi.nlm.nih.gov/pubmed/32613587
http://dx.doi.org/10.1186/s40658-020-00314-x
_version_ 1783553010852429824
author Marin, I.
Rydèn, T.
Van Essen, M.
Svensson, J.
Gracheva, N.
Köster, U.
Zeevaart, J. R.
van der Meulen, N. P.
Müller, C.
Bernhardt, P.
author_facet Marin, I.
Rydèn, T.
Van Essen, M.
Svensson, J.
Gracheva, N.
Köster, U.
Zeevaart, J. R.
van der Meulen, N. P.
Müller, C.
Bernhardt, P.
author_sort Marin, I.
collection PubMed
description BACKGROUND: It has been proposed, and preclinically demonstrated, that (161)Tb is a better alternative to (177)Lu for the treatment of small prostate cancer lesions due to its high emission of low-energy electrons. (161)Tb also emits photons suitable for single-photon emission computed tomography (SPECT) imaging. This study aims to establish a SPECT protocol for (161)Tb imaging in the clinic. MATERIALS AND METHODS: Optimal settings using various γ-camera collimators and energy windows were explored by imaging a Jaszczak phantom, including hollow-sphere inserts, filled with (161)Tb. The collimators examined were extended low-energy general purpose (ELEGP), medium-energy general purpose (MEGP), and low-energy high resolution (LEHR), respectively. In addition, three ordered subset expectation maximization (OSEM) algorithms were investigated: attenuation-corrected OSEM (A-OSEM); attenuation and dual- or triple-energy window scatter-corrected OSEM (AS-OSEM); and attenuation, scatter, and collimator-detector response-corrected OSEM (ASC-OSEM), where the latter utilized Monte Carlo-based reconstruction. Uniformity corrections, using intrinsic and extrinsic correction maps, were also investigated. Image quality was assessed by estimated recovery coefficients (RC), noise, and signal-to-noise ratio (SNR). Sensitivity was determined using a circular flat phantom. RESULTS: The best RC and SNR were obtained at an energy window between 67.1 and 82.1 keV. Ring artifacts, caused by non-uniformity, were removed with extrinsic uniformity correction for the energy window between 67.1 and 82.1 keV, but not with intrinsic correction. Analyzing the lower energy window between 48.9 and 62.9 keV, the ring artifacts remained after uniformity corrections. The recovery was similar for the different collimators when using a specific OSEM reconstruction. Recovery and SNR were highest for ASC-OSEM, followed by AS-OSEM and A-OSEM. When using the optimized parameter setting, the resolution of (161)Tb was higher than for (177)Lu (8.4 ± 0.7 vs. 10.4 ± 0.6 mm, respectively). The sensitivities for (161)Tb and (177)Lu were 7.41 and 8.46 cps/MBq, respectively. CONCLUSION: SPECT with high resolution is feasible with (161)Tb; however, extrinsic uniformity correction is recommended to avoid ring artifacts. The LEHR collimator was the best choice of the three tested to obtain a high-resolution image. Due to the complex emission spectrum of low-energy photons, window-based scatter correction had a minor impact on the image quality compared to using attenuation correction only. On the other hand, performing attenuation, scatter, and collimator-detector correction clearly improved image quality. Based on these data, SPECT-based dosimetry for (161)Tb-labeled radiopharmaceuticals is feasible.
format Online
Article
Text
id pubmed-7329978
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73299782020-07-07 Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb Marin, I. Rydèn, T. Van Essen, M. Svensson, J. Gracheva, N. Köster, U. Zeevaart, J. R. van der Meulen, N. P. Müller, C. Bernhardt, P. EJNMMI Phys Original Research BACKGROUND: It has been proposed, and preclinically demonstrated, that (161)Tb is a better alternative to (177)Lu for the treatment of small prostate cancer lesions due to its high emission of low-energy electrons. (161)Tb also emits photons suitable for single-photon emission computed tomography (SPECT) imaging. This study aims to establish a SPECT protocol for (161)Tb imaging in the clinic. MATERIALS AND METHODS: Optimal settings using various γ-camera collimators and energy windows were explored by imaging a Jaszczak phantom, including hollow-sphere inserts, filled with (161)Tb. The collimators examined were extended low-energy general purpose (ELEGP), medium-energy general purpose (MEGP), and low-energy high resolution (LEHR), respectively. In addition, three ordered subset expectation maximization (OSEM) algorithms were investigated: attenuation-corrected OSEM (A-OSEM); attenuation and dual- or triple-energy window scatter-corrected OSEM (AS-OSEM); and attenuation, scatter, and collimator-detector response-corrected OSEM (ASC-OSEM), where the latter utilized Monte Carlo-based reconstruction. Uniformity corrections, using intrinsic and extrinsic correction maps, were also investigated. Image quality was assessed by estimated recovery coefficients (RC), noise, and signal-to-noise ratio (SNR). Sensitivity was determined using a circular flat phantom. RESULTS: The best RC and SNR were obtained at an energy window between 67.1 and 82.1 keV. Ring artifacts, caused by non-uniformity, were removed with extrinsic uniformity correction for the energy window between 67.1 and 82.1 keV, but not with intrinsic correction. Analyzing the lower energy window between 48.9 and 62.9 keV, the ring artifacts remained after uniformity corrections. The recovery was similar for the different collimators when using a specific OSEM reconstruction. Recovery and SNR were highest for ASC-OSEM, followed by AS-OSEM and A-OSEM. When using the optimized parameter setting, the resolution of (161)Tb was higher than for (177)Lu (8.4 ± 0.7 vs. 10.4 ± 0.6 mm, respectively). The sensitivities for (161)Tb and (177)Lu were 7.41 and 8.46 cps/MBq, respectively. CONCLUSION: SPECT with high resolution is feasible with (161)Tb; however, extrinsic uniformity correction is recommended to avoid ring artifacts. The LEHR collimator was the best choice of the three tested to obtain a high-resolution image. Due to the complex emission spectrum of low-energy photons, window-based scatter correction had a minor impact on the image quality compared to using attenuation correction only. On the other hand, performing attenuation, scatter, and collimator-detector correction clearly improved image quality. Based on these data, SPECT-based dosimetry for (161)Tb-labeled radiopharmaceuticals is feasible. Springer International Publishing 2020-07-01 /pmc/articles/PMC7329978/ /pubmed/32613587 http://dx.doi.org/10.1186/s40658-020-00314-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Research
Marin, I.
Rydèn, T.
Van Essen, M.
Svensson, J.
Gracheva, N.
Köster, U.
Zeevaart, J. R.
van der Meulen, N. P.
Müller, C.
Bernhardt, P.
Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
title Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
title_full Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
title_fullStr Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
title_full_unstemmed Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
title_short Establishment of a clinical SPECT/CT protocol for imaging of (161)Tb
title_sort establishment of a clinical spect/ct protocol for imaging of (161)tb
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329978/
https://www.ncbi.nlm.nih.gov/pubmed/32613587
http://dx.doi.org/10.1186/s40658-020-00314-x
work_keys_str_mv AT marini establishmentofaclinicalspectctprotocolforimagingof161tb
AT rydent establishmentofaclinicalspectctprotocolforimagingof161tb
AT vanessenm establishmentofaclinicalspectctprotocolforimagingof161tb
AT svenssonj establishmentofaclinicalspectctprotocolforimagingof161tb
AT grachevan establishmentofaclinicalspectctprotocolforimagingof161tb
AT kosteru establishmentofaclinicalspectctprotocolforimagingof161tb
AT zeevaartjr establishmentofaclinicalspectctprotocolforimagingof161tb
AT vandermeulennp establishmentofaclinicalspectctprotocolforimagingof161tb
AT mullerc establishmentofaclinicalspectctprotocolforimagingof161tb
AT bernhardtp establishmentofaclinicalspectctprotocolforimagingof161tb